AI & Healthcare News ・ ⚖️ Digital therapeutics and regulation

Digital Health Roundup: BD’s $19Bn Tariff Deal, AI’s Trust Question, GLP-1 Tools Chasing Proof

insights.citeline.com · 10/20 16:01 UTC

BD has struck a $19bn US investment deal for relief from future Section 232 tariffs. UltraSight raised $24m for AI echocardiography, and Elixir is preparing a Japan launch. Reset Health reported GLP-1 adherence data as it courts NICE.

Read the original (insights.citeline.com)

See it in the digest → ・ See this issue →